SAT1 and neoplasm: While additional translational studies with mouse xenograft models are required, these initial findings suggest that modulation of SAT1 beneficially impacts tumor viability both alone and in combination with radiation or chemotherapy and provides a conceptual framework for a nanomedicine-based approach for the delivery siRNA to the tumor site.